Clinical Trial

The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to examine the predictive value of metastatic gastric mesenteries, which contains metastatic lymph node, in 6 gastric mesenteries; and importantly, to further evaluate the relationship between the number of metastatic gastric mesenteries and prognosis in the gastric cancer patients who received D2+complete mesogastric excision (CME).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-17.
Status change: Not Yet Recruiting → Recruiting 2026-03-08
Trial Details
NCT Number NCT07139418
Lead Sponsor Jichao Qin
Collaborators: Zhejiang University
Conditions Gastric Carcinoma
Enrollment 400 participants
Start Date 2025-10-07
Primary Completion 2027-08-30 (estimated)
Study Completion 2030-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-11